Skip to main content
Top
Published in:

Open Access 17-05-2024 | Spondyloarthropathy | Review

Diagnosis, monitoring, and management of axial spondyloarthritis

Authors: Olena Zimba, Burhan Fatih Kocyigit, Mariusz Korkosz

Published in: Rheumatology International | Issue 8/2024

Login to get access

Abstract

Axial spondyloarthritis (axSpA) is a chronic condition predominantly affecting the spine and sacroiliac joints. This article provides an in-depth overview of the current approaches to diagnosing, monitoring, and managing axSpA, including insights into developing terminology and diagnostic difficulties. A substantial portion of the debate focuses on the challenging diagnostic procedure, noting the difficulty of detecting axSpA early, particularly before the appearance of radiologic structural changes. Despite normal laboratory parameters, more than half of axSpA patients experience symptoms. X-ray and magnetic resonance imaging (MRI) are essential for evaluating structural damage and inflammation. MRI can be beneficial when there is no visible structural damage on X-ray as it can help unravel bone marrow edema (BME) as a sign of ongoing inflammation. The management covers both non-pharmacological and pharmacological approaches. Lifestyle modifications, physical activity, and patient education are essential components of the management. Pharmacological therapy, including nonsteroidal anti-inflammatory drugs (NSAIDs) and biologic disease-modifying anti-rheumatic drugs (bDMARDs), are explored, emphasizing individualized treatment. To effectively manage axSpA, a comprehensive and well-coordinated approach is necessary, emphasizing the significance of a multidisciplinary team. Telehealth applications play a growing role in axSpA management, notably in reducing diagnostic delays and facilitating remote monitoring. In conclusion, this article underlines diagnostic complexities and emphasizes the changing strategy of axSpA treatment. The nuanced understanding offered here is designed to guide clinicians, researchers, and healthcare providers toward a more comprehensive approach to axSpA diagnosis and care.
Literature
6.
go back to reference Rudwaleit M, Landewé R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776. https://doi.org/10.1136/ard.2009.108217CrossRefPubMed Rudwaleit M, Landewé R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776. https://​doi.​org/​10.​1136/​ard.​2009.​108217CrossRefPubMed
20.
go back to reference van den Berg R, de Hooge M, van Gaalen F, Reijnierse M, Huizinga T, van der Heijde D (2013) Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52:1492–1499. https://doi.org/10.1093/rheumatology/ket164CrossRefPubMed van den Berg R, de Hooge M, van Gaalen F, Reijnierse M, Huizinga T, van der Heijde D (2013) Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52:1492–1499. https://​doi.​org/​10.​1093/​rheumatology/​ket164CrossRefPubMed
21.
go back to reference Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed
23.
go back to reference Bennett AN, McGonagle D, O’Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58:3413–3418. https://doi.org/10.1002/art.24024CrossRefPubMed Bennett AN, McGonagle D, O’Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58:3413–3418. https://​doi.​org/​10.​1002/​art.​24024CrossRefPubMed
24.
go back to reference Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewé R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1–44. https://doi.org/10.1136/ard.2008.104018CrossRef Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewé R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1–44. https://​doi.​org/​10.​1136/​ard.​2008.​104018CrossRef
26.
34.
42.
go back to reference Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, den Broeder AA (2024) Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study. Scand J Rheumatol 53:180–187. https://doi.org/10.1080/03009742.2023.2213509CrossRefPubMed Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, den Broeder AA (2024) Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study. Scand J Rheumatol 53:180–187. https://​doi.​org/​10.​1080/​03009742.​2023.​2213509CrossRefPubMed
43.
go back to reference van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R; Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818. https://doi.org/10.1136/ard.2008.100826CrossRef van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R; Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818. https://​doi.​org/​10.​1136/​ard.​2008.​100826CrossRef
45.
go back to reference Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D; Assessment of SpondyloArthritis international Society (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47–53. https://doi.org/10.1136/ard.2010.138594CrossRef Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D; Assessment of SpondyloArthritis international Society (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47–53. https://​doi.​org/​10.​1136/​ard.​2010.​138594CrossRef
46.
go back to reference Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M, ASAS-FLARE study group, (2018) An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis 77:124–127. https://doi.org/10.1136/annrheumdis-2017-212178CrossRefPubMed Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M, ASAS-FLARE study group, (2018) An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis 77:124–127. https://​doi.​org/​10.​1136/​annrheumdis-2017-212178CrossRefPubMed
47.
49.
52.
go back to reference Biallas RL, Dean LE, Davidson L, Hollick R, Pathan E, Robertson L, Jones GT, Macfarlane GJ, Rotariu O (2022) Role of metrology in axial spondyloarthritis: does it provide unique information in assessing patients and predicting outcome? results from the British society for rheumatology biologic register for ankylosing spondylitis. Arthritis Care Res (Hoboken) 74:665–674. https://doi.org/10.1002/acr.24500CrossRefPubMed Biallas RL, Dean LE, Davidson L, Hollick R, Pathan E, Robertson L, Jones GT, Macfarlane GJ, Rotariu O (2022) Role of metrology in axial spondyloarthritis: does it provide unique information in assessing patients and predicting outcome? results from the British society for rheumatology biologic register for ankylosing spondylitis. Arthritis Care Res (Hoboken) 74:665–674. https://​doi.​org/​10.​1002/​acr.​24500CrossRefPubMed
62.
go back to reference Lukas C, Braun J, van der Heijde D, Hermann KG et al (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 34:862–870PubMed Lukas C, Braun J, van der Heijde D, Hermann KG et al (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 34:862–870PubMed
63.
go back to reference Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, Conner-Spady B, Palsat J, Lambert RG (2005) Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53:703–709. https://doi.org/10.1002/art.21445CrossRefPubMed Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, Conner-Spady B, Palsat J, Lambert RG (2005) Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53:703–709. https://​doi.​org/​10.​1002/​art.​21445CrossRefPubMed
67.
go back to reference Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, Ramiro S, van der Heijde D, Nikiphorou E (2023) Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis 82:142–152. https://doi.org/10.1136/ard-2022-223297CrossRefPubMed Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, Ramiro S, van der Heijde D, Nikiphorou E (2023) Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis 82:142–152. https://​doi.​org/​10.​1136/​ard-2022-223297CrossRefPubMed
76.
go back to reference Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64:1388–1398. https://doi.org/10.1002/art.33465CrossRefPubMed Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64:1388–1398. https://​doi.​org/​10.​1002/​art.​33465CrossRefPubMed
79.
80.
go back to reference Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M (2016) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75:1438–1443. https://doi.org/10.1136/annrheumdis-2015-207897CrossRefPubMed Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M (2016) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75:1438–1443. https://​doi.​org/​10.​1136/​annrheumdis-2015-207897CrossRefPubMed
81.
go back to reference Proft F, Muche B, Listing J, Rios-Rodriguez V, Sieper J, Poddubnyy D (2017) Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of structural damage in the spine over two years in patients with ankylosing spondylitis (CONSUL)—an open-label randomized controlled multicenter trial. BMJ Open 7:e014591. https://doi.org/10.1136/bmjopen-2016-014591CrossRefPubMedPubMedCentral Proft F, Muche B, Listing J, Rios-Rodriguez V, Sieper J, Poddubnyy D (2017) Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of structural damage in the spine over two years in patients with ankylosing spondylitis (CONSUL)—an open-label randomized controlled multicenter trial. BMJ Open 7:e014591. https://​doi.​org/​10.​1136/​bmjopen-2016-014591CrossRefPubMedPubMedCentral
82.
go back to reference Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landewé R, Van den Bosch F, Falzon L, Ramiro S (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3:e000397. https://doi.org/10.1136/rmdopen-2016-000397CrossRefPubMedPubMedCentral Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landewé R, Van den Bosch F, Falzon L, Ramiro S (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3:e000397. https://​doi.​org/​10.​1136/​rmdopen-2016-000397CrossRefPubMedPubMedCentral
84.
go back to reference Shentu H, Sha S, He Y, He M, Dong N, Huang Z, Lai H, Chen M, Huang J, Huang X (2024) Efficacy of TNF-α inhibitors in the treatment of nr-axSpA: a systematic review and meta-analysis based on randomized controlled trials. Int Arch Allergy Immunol 1:1–10. https://doi.org/10.1159/000536601CrossRef Shentu H, Sha S, He Y, He M, Dong N, Huang Z, Lai H, Chen M, Huang J, Huang X (2024) Efficacy of TNF-α inhibitors in the treatment of nr-axSpA: a systematic review and meta-analysis based on randomized controlled trials. Int Arch Allergy Immunol 1:1–10. https://​doi.​org/​10.​1159/​000536601CrossRef
86.
go back to reference Barkham N, Keen HI, Coates LC, O’Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60:946–954. https://doi.org/10.1002/art.24408CrossRefPubMed Barkham N, Keen HI, Coates LC, O’Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60:946–954. https://​doi.​org/​10.​1002/​art.​24408CrossRefPubMed
89.
go back to reference Deodhar A, Poddubnyy D, Pacheco-Tena C et al (2019) Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen-week results from a phase III randomized, double-blind, placebo-controlled trial in patients with prior inadequate response to or intolerance of tumor necrosis factor inhibitors. Arthritis Rheumatol 71:599–611. https://doi.org/10.1002/art.40753CrossRefPubMedPubMedCentral Deodhar A, Poddubnyy D, Pacheco-Tena C et al (2019) Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen-week results from a phase III randomized, double-blind, placebo-controlled trial in patients with prior inadequate response to or intolerance of tumor necrosis factor inhibitors. Arthritis Rheumatol 71:599–611. https://​doi.​org/​10.​1002/​art.​40753CrossRefPubMedPubMedCentral
97.
go back to reference Lindström U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d’Elia H, Jacobsson LTH, Askling J (2021) Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis 80:1445–1452. https://doi.org/10.1136/annrheumdis-2021-220420CrossRefPubMed Lindström U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d’Elia H, Jacobsson LTH, Askling J (2021) Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis 80:1445–1452. https://​doi.​org/​10.​1136/​annrheumdis-2021-220420CrossRefPubMed
98.
go back to reference Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T (2019) Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Ann Rheum Dis 78:473–479. https://doi.org/10.1136/annrheumdis-2018-214273CrossRefPubMed Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, Porter B, Das Gupta A, Pricop L, Fox T (2019) Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Ann Rheum Dis 78:473–479. https://​doi.​org/​10.​1136/​annrheumdis-2018-214273CrossRefPubMed
102.
go back to reference Kjeken I, Bø I, Rønningen A, Spada C, Mowinckel P, Hagen KB, Dagfinrud H (2013) A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J Rehabil Med 45:260–267. https://doi.org/10.2340/16501977-1078CrossRefPubMed Kjeken I, Bø I, Rønningen A, Spada C, Mowinckel P, Hagen KB, Dagfinrud H (2013) A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J Rehabil Med 45:260–267. https://​doi.​org/​10.​2340/​16501977-1078CrossRefPubMed
103.
go back to reference Rademacher J, Müllner H, Diekhoff T, Haibel H, Igel S, Pohlmann D, Proft F, Protopopov M, Rios Rodriguez V, Torgutalp M, Pleyer U, Poddubnyy D (2023) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol 75:210–219. https://doi.org/10.1002/art.42315CrossRefPubMed Rademacher J, Müllner H, Diekhoff T, Haibel H, Igel S, Pohlmann D, Proft F, Protopopov M, Rios Rodriguez V, Torgutalp M, Pleyer U, Poddubnyy D (2023) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol 75:210–219. https://​doi.​org/​10.​1002/​art.​42315CrossRefPubMed
107.
go back to reference Gudu T, Jadon DR (2020) Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20975888CrossRefPubMedPubMedCentral Gudu T, Jadon DR (2020) Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20975888CrossRefPubMedPubMedCentral
108.
go back to reference Garrido-Cumbrera M, Bundy C, Navarro-Compán V, Makri S, Sanz-Gómez S, Christen L, Mahapatra R, Delgado-Domínguez CJ, Poddubnyy D (2021) Patient-reported impact of axial spondyloarthritis on working life: results from the european map of axial spondyloarthritis survey. Arthritis Care Res (Hoboken) 73:1826–1833. https://doi.org/10.1002/acr.24426CrossRefPubMed Garrido-Cumbrera M, Bundy C, Navarro-Compán V, Makri S, Sanz-Gómez S, Christen L, Mahapatra R, Delgado-Domínguez CJ, Poddubnyy D (2021) Patient-reported impact of axial spondyloarthritis on working life: results from the european map of axial spondyloarthritis survey. Arthritis Care Res (Hoboken) 73:1826–1833. https://​doi.​org/​10.​1002/​acr.​24426CrossRefPubMed
115.
go back to reference von Rohr S, Knitza J, Grahammer M, Schmalzing M, Kuhn S, Schett G, Ramming A, Labinsky H (2023) Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study. Rheumatol Int 43:1905–1911. https://doi.org/10.1007/s00296-023-05392-5CrossRef von Rohr S, Knitza J, Grahammer M, Schmalzing M, Kuhn S, Schett G, Ramming A, Labinsky H (2023) Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study. Rheumatol Int 43:1905–1911. https://​doi.​org/​10.​1007/​s00296-023-05392-5CrossRef
Metadata
Title
Diagnosis, monitoring, and management of axial spondyloarthritis
Authors
Olena Zimba
Burhan Fatih Kocyigit
Mariusz Korkosz
Publication date
17-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-024-05615-3

Other articles of this Issue 8/2024

Rheumatology International 8/2024 Go to the issue

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Live: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more